IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection. - Wikidata - awgldk - TriplyDB

IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection.

IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection.

http://www.wikidata.org/entity/Q34279852

about

Genetic Markers of the Host in Persons Living with HTLV-1, HIV and HCV Infections A multicentre molecular analysis of hepatitis B and blood-borne virus coinfections in Viet Nam Lack of evidence to support the association of a single IL28B genotype SNP rs12979860 with the HTLV-1 clinical outcomes and proviral load.Human genes involved in hepatitis B virus infection.IL28B SNP rs12979860 is a critical predictor for on-treatment and sustained virologic response in patients with hepatitis C virus genotype-1 infection IL28B gene polymorphism SNP rs8099917 genotype GG is associated with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-1 carriers.Interferon lambda: opportunities, risks, and uncertainties in the fight against HCV.IFN-λ4: the paradoxical new member of the interferon lambda family.Association analysis between SNPs in IL-28B gene and the progress of hepatitis B infection in Han Chinese.Understanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon-alpha therapy via mathematical modeling Associations of IFN-γ rs2430561 T/A, IL28B rs12979860 C/T and ERα rs2077647 T/C polymorphisms with outcomes of hepatitis B virus infection: a meta-analysis.IL28B polymorphism correlates with active hepatitis in patients with HBeAg-negative chronic hepatitis B.Association between IL28B polymorphisms and spontaneous clearance of hepatitis B virus infection.Association of polymorphisms in interleukin-18 and interleukin-28B genes with outcomes of hepatitis B virus infections: a meta-analysis.IL28B gene polymorphisms in mono- and HIV-coinfected chronic hepatitis C patients.IL28B genotype does not correlate with HIV control in African Americans.Role of IFN-ks, IFN-ks related genes and the DEPDC5 gene in Hepatitis B virus-related liver disease.The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin Long-term antiviral efficacy of entecavir and liver histology improvement in Chinese patients with hepatitis B virus-related cirrhosis.Pharmacogenomics of hepatitis C infections: personalizing therapy.IFNL3 genotype is associated with differential induction of IFNL3 in primary human hepatocytes.The Correlation Between Interferon Lambda 3 Gene Polymorphisms and Susceptibility to Hepatitis B Virus Infection.Absence of correlation between IL-28B gene polymorphisms and the clinical presentation of chronic hepatitis B in an Amazon Brazilian population.IL28B and the control of hepatitis C virus infection.Translating pharmacogenetics into clinical practice: interleukin (IL)28B and inosine triphosphatase (ITPA) polymophisms in hepatitis C virus (HCV) infection.Host genomics and HCV treatment response.IL28B polymorphisms as a pretreatment predictor of response to HCV treatment.Individualized therapy for hepatitis C infection: focus on the interleukin-28B polymorphism in directing therapy.The role of pharmacogenetics in the treatment of chronic hepatitis C infection.Relationship between polymorphisms near the IL28B gene and spontaneous HBsAg seroclearance: a systematic review and meta-analysis.Interleukin 28B genetic polymorphism and hepatitis B virus infection Gene-disease association with human IFNL locus polymorphisms extends beyond hepatitis C virus infections.Gene polymorphisms of interleukin 28B and the risk to chronic hepatitis B virus infection in Thai.Paradoxical expression of IL-28B mRNA in peripheral blood in human T-cell leukemia virus type-1 mono-infection and co-infection with hepatitis C virus.IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-α.Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection.IFN-stimulated gene expression is independent of the IFNL4 genotype in chronic HIV-1 infection.Frequency of interleukin 28B rs12979860 C>T variants in Filipino patients chronically infected with hepatitis B virus.Profile of HIV subtypes in HIV/HBV- and HIV/HCV-coinfected patients in Southern Brazil.The relationship between IL-28B polymorphisms and the response to peginterferon alfa-2a monotherapy in anti-HBe-positive patients with chronic HBV infection.

P2860

Q26768628-F183FE03-D4E6-444F-853F-9DEED9A133EB Q28480392-CFEA30F7-34FA-4026-9AF6-11FDCD5391DA Q31109635-0FDBE8B9-E0A1-42FC-A8EB-4B47568AE23C Q33801320-19ECC71A-A736-48AF-97BE-7F53EAEB2059 Q33867243-1B40A999-155F-4DAD-9B1D-12E5897E3B95 Q34214760-5F81FCE7-8FC7-4454-8CDB-6252D7E3938B Q34433087-079FB640-F8BA-448C-853F-FCC711547CA4 Q34439917-C08F05A3-5AB8-4CBA-AEDE-46E93A43DDDC Q34507102-A0A7A3E0-E52A-4109-B4DA-4F3036880DC1 Q34577514-2CCB772D-E9C1-4600-8952-DF1B3A5F83BB Q34604379-309E82C5-B40F-440F-A7EE-2462BC4594B8 Q34612816-635B0F47-0425-4392-A46D-605C03F5114E Q34853230-6529AECB-B2D0-4838-9773-962AEDBD5C08 Q34985468-B7F7A80C-1864-4A7D-B97D-ED457A269FF7 Q35146008-9D4E03C7-F044-4DE3-952E-5DCA2F6E2AB8 Q35205904-77E04647-628A-4B98-B25D-21D864CF5911 Q35208006-33EF61F4-F719-4085-9866-5019B7302DE3 Q35812034-F6E5F2BD-AC1D-44E7-A388-069CB171B4F7 Q35819595-CAD5698B-03EB-4B95-A92D-233E732BCF07 Q36632938-1D7A98EA-A67E-464A-9AB7-44895768FDCF Q36766899-3EFD5BDA-E6AF-42F3-86C0-16F17B6FA16D Q36923172-81DF82DC-20DB-4C24-B3EB-A95AE366A599 Q37731275-3A2258CA-8DE6-4175-964B-B2553A61D2BB Q37800518-8C0B2F7C-4E3B-457D-A0C5-4008C1AD06C0 Q37879701-CDAEE79B-5A79-4BD6-B501-0AE48196C733 Q37932036-C94D5681-407B-4CF4-9125-F492B8E02A4C Q38053543-EC1BA8EE-D6BC-48A7-8672-41CAED5C1E6E Q38136078-62AAA022-48C3-4B97-B218-69E0524766CF Q38151586-0A09B12B-5CAF-45EC-B104-FFCD2FA1E383 Q38179534-7A8126AB-5A6A-4128-BDFC-19350BAF97C3 Q38251526-E9D1D6F3-BCAD-44B2-8FDC-C6F4D0CD518D Q38859455-34F268E3-9161-4353-9986-FB2ED8665A23 Q39137625-D773823E-F34E-440C-BDC3-ECC590EBDD90 Q39396346-913B568A-B80E-411F-9E78-648AFB0BDAA1 Q39488926-E2B21A88-C5BD-4392-A152-B63A230E0282 Q40476048-F5D93607-648F-447E-827E-4DF520482766 Q40564211-EA99C0F8-35A6-4112-8D16-47C39517F0EB Q41665537-2EC7510D-88A2-4BB5-B7C2-662CD40988B4 Q41929282-91A806B1-B5C6-4017-8B02-BA58EA15A8B0 Q42212812-6A897DE1-035E-4EBA-A03F-C198479421BB

P2860

IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection.

http://www.wikidata.org/entity/Q34279852

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection.

@ast

IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection.

@en

IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection.

@nl

type

label

IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection.

@ast

IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection.

@en

IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection.

@nl

prefLabel

IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection.

@ast

IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection.

@en

IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection.

@nl

P1433

Q34279852-155C19E6-BE32-4AAD-BB4C-D602D17C55EC

P1476

Q34279852-FC153A40-C611-405B-A71C-39F49D10E9F3

P2093

Q34279852-116368C0-1392-4584-B518-28B0190B47ED

Q34279852-1717388E-5DD6-4049-9DDA-43C3975C97C2

Q34279852-36C6B57E-8E6D-4457-8CDF-A1651D8FC377

Q34279852-3D897DFD-8B21-43B6-8454-5A343B19EB96

Q34279852-6CC4D335-6465-4579-88D8-C3A2316F55F0

Q34279852-B1B2BF9D-C0A4-4BBA-8F22-87024385CD23

Q34279852-E36FFD8C-F3F9-427A-8497-E9646AE97EFF

P2860

Q34279852-05A26E0A-8E20-4F33-A934-B55F3DA28E97

Q34279852-197EA3EE-E2EF-49C2-A824-8486AA75F67F

Q34279852-210D5EC4-593B-4955-B7B1-06634A41B5DF

Q34279852-4E771ECA-C8FF-47F0-9240-D1365E9377B5

Q34279852-5EBF22F7-7503-44A7-A34C-F781FAEFA7A2

Q34279852-644EF065-E62C-4ED5-804D-AB7FD94E22EC

Q34279852-6AB91F0F-3DDC-46CC-850B-195FB0CDFCD4

Q34279852-6EFC29AF-83A0-4AC4-ABAF-C9E2257EB15F

Q34279852-9EC3799A-A453-4D60-9E65-30ADA413701A

Q34279852-B26B4177-42B8-420A-8F4B-0A1788180442

P304

Q34279852-0D836B9A-0628-49D2-B2BA-326625061BCD

P31

Q34279852-6881316D-4FF9-4AC3-8293-E152090403E8

P356

Q34279852-B9A8831D-2850-4703-A2A5-1EC80E1AA7FC

P407

Q34279852-4FE425B0-FA67-4D68-B64C-7BC74D014FFA

P433

Q34279852-F9409A12-9772-4AAC-8345-BA1733D896DF

P478

Q34279852-F1577E7A-18F6-4D1F-973F-68651FEF4647

P50

Q34279852-8EEDE679-EDED-4617-B35B-C138A979717F

Q34279852-FA9CFC6C-4D7C-4716-A4A9-70850A89543D

P577

Q34279852-5F7CB2A2-50C1-4AC7-8DD1-5F3DA95B69C9

P5875

Q34279852-784ED87A-EC50-4D71-81AD-2010CDB9C41A

P698

Q34279852-1DD7B2D5-7D41-4B1B-8485-E5971BA132E0

P932

Q34279852-192F2429-45BE-4FE9-904A-B0E1E021DF80

P356

P1433

The Journal of Infectious Diseases

P1476

IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection.

@en

P2093

Chloe L Thio

http://www.w3.org/2001/XMLSchema#string

Gregory D Kirk

http://www.w3.org/2001/XMLSchema#string

James J Goedert

http://www.w3.org/2001/XMLSchema#string

Maureen P Martin

http://www.w3.org/2001/XMLSchema#string

Shehnaz K Hussain

http://www.w3.org/2001/XMLSchema#string

W Keith Hoots

http://www.w3.org/2001/XMLSchema#string

Ying Qi

http://www.w3.org/2001/XMLSchema#string

P2860

Common genetic variation and the control of HIV-1 in humans

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity

Lambda interferon inhibits human immunodeficiency virus type 1 infection of macrophages

Lambda interferon inhibits hepatitis B and C virus replication.

1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases

Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice.

Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence

P304

1749-1753

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/657146

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

202

http://www.w3.org/2001/XMLSchema#string

P50

Mary Carrington

Susan Buchbinder

P577

2010-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47555195

http://www.w3.org/2001/XMLSchema#string

P698

20977343

http://www.w3.org/2001/XMLSchema#string

P932

2974014

http://www.w3.org/2001/XMLSchema#string